- Home
- TENB vs PCVX Comparison
TENB vs PCVX Comparison
Compare TENB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENB
- PCVX
- Stock Information
- Founded
- TENB 2002
- PCVX 2013
- Country
- TENB United States
- PCVX United States
- Employees
- TENB N/A
- PCVX N/A
- Industry
- TENB Computer Software: Prepackaged Software
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TENB Technology
- PCVX Health Care
- Exchange
- TENB Nasdaq
- PCVX Nasdaq
- Market Cap
- TENB 3.5B
- PCVX 4.0B
- IPO Year
- TENB 2018
- PCVX 2020
- Fundamental
- Price
- TENB $27.44
- PCVX $45.93
- Analyst Decision
- TENB Buy
- PCVX Strong Buy
- Analyst Count
- TENB 18
- PCVX 7
- Target Price
- TENB $39.88
- PCVX $101.67
- AVG Volume (30 Days)
- TENB 1.2M
- PCVX 1.3M
- Earning Date
- TENB 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- TENB N/A
- PCVX N/A
- EPS Growth
- TENB N/A
- PCVX N/A
- EPS
- TENB N/A
- PCVX N/A
- Revenue
- TENB $974,603,000.00
- PCVX N/A
- Revenue This Year
- TENB $12.22
- PCVX N/A
- Revenue Next Year
- TENB $7.62
- PCVX N/A
- P/E Ratio
- TENB N/A
- PCVX N/A
- Revenue Growth
- TENB 11.05
- PCVX N/A
- 52 Week Low
- TENB $27.01
- PCVX $27.66
- 52 Week High
- TENB $45.45
- PCVX $103.30
- Technical
- Relative Strength Index (RSI)
- TENB 35.91
- PCVX 63.80
- Support Level
- TENB $27.01
- PCVX $40.14
- Resistance Level
- TENB $28.39
- PCVX $45.90
- Average True Range (ATR)
- TENB 0.81
- PCVX 2.15
- MACD
- TENB -0.15
- PCVX -0.07
- Stochastic Oscillator
- TENB 12.09
- PCVX 98.26
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.